IM Cannabis Corp. (IMCC)

USD 1.73

(2.37%)

Long Term Debt Summary of IM Cannabis Corp.

  • IM Cannabis Corp.'s latest annual long term debt in 2023 was 394 Thousand CAD , down -73.27% from previous year.
  • IM Cannabis Corp.'s latest quarterly long term debt in 2024 Q2 was 401 Thousand CAD , down 0.0% from previous quarter.
  • IM Cannabis Corp. reported annual long term debt of 1.47 Million CAD in 2022, down -91.91% from previous year.
  • IM Cannabis Corp. reported annual long term debt of 18.21 Million USD in 2021, up 2112.88% from previous year.
  • IM Cannabis Corp. reported quarterly long term debt of 401 Thousand CAD for 2024 Q1, up 1.78% from previous quarter.
  • IM Cannabis Corp. reported quarterly long term debt of 1.38 Million USD for 2023 Q1, down -6.17% from previous quarter.

Annual Long Term Debt Chart of IM Cannabis Corp. (2023 - 2003)

Historical Annual Long Term Debt of IM Cannabis Corp. (2023 - 2003)

Year Long Term Debt Long Term Debt Growth
2023 394 Thousand CAD -73.27%
2022 1.47 Million CAD -91.91%
2021 18.21 Million USD 2112.88%
2020 823 Thousand CAD -7.63%
2019 891 Thousand CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD 0.0%
2006 - CAD 0.0%
2005 - CAD 0.0%
2004 - CAD 0.0%
2003 - CAD 0.0%

Peer Long Term Debt Comparison of IM Cannabis Corp.

Name Long Term Debt Long Term Debt Difference
ANI Pharmaceuticals, Inc. 309.66 Million USD 99.873%
Aquestive Therapeutics, Inc. 91.07 Million USD 99.567%
Collegium Pharmaceutical, Inc. 489.96 Million USD 99.92%
Cosmos Health Inc. 3.03 Million USD 87.02%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -1652.357%
Esperion Therapeutics, Inc. 501.54 Million USD 99.921%
Cronos Group Inc. 1.55 Million USD 74.727%
Incannex Healthcare Limited 210 Thousand USD -87.619%
Kala Pharmaceuticals, Inc. 34.19 Million USD 98.848%
Lifecore Biomedical, Inc. 120.51 Million USD 99.673%
Regencell Bioscience Holdings Limited - USD -Infinity%
Sunshine Biopharma, Inc. 539.03 Thousand USD 26.906%
Sunshine Biopharma, Inc. 539.03 Thousand USD 26.906%
SCYNEXIS, Inc. 12.15 Million USD 96.76%
Safety Shot Inc 304.9 Thousand USD -29.22%
Theratechnologies Inc. 51.26 Million USD 99.231%
Alpha Teknova, Inc. 13.25 Million USD 97.027%
Universe Pharmaceuticals INC - USD -Infinity%
Pacira BioSciences, Inc. 513.79 Million USD 99.923%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -352.874%
Dynavax Technologies Corporation 252.41 Million USD 99.844%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 99.921%
Radius Health, Inc. 339.66 Million USD 99.884%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -236.381%
Alvotech 1.02 Billion USD 99.962%
Intra-Cellular Therapies, Inc. 13.32 Million USD 97.043%
SIGA Technologies, Inc. 335.99 Thousand USD -17.265%
Shineco, Inc. 10.01 Million USD 96.067%
Silver Spike Investment Corp. - USD -Infinity%
Journey Medical Corporation 14.62 Million USD 97.305%
Petros Pharmaceuticals, Inc. 6.85 Million USD 94.254%
Embecta Corp. 1.62 Billion USD 99.976%
Harrow Health, Inc. 183.17 Million USD 99.785%
Procaps Group, S.A. 28.41 Million USD 98.613%
Biofrontera Inc. 804 Thousand USD 50.995%
DURECT Corporation 2.7 Million USD 85.418%
PainReform Ltd. 30 Thousand USD -1213.333%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 98.813%
OptiNose, Inc. 611 Thousand USD 35.516%
RedHill Biopharma Ltd. 455 Thousand USD 13.407%
Organogenesis Holdings Inc. 60.74 Million USD 99.351%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 96.918%
ProPhase Labs, Inc. 10.25 Million USD 96.159%
Phibro Animal Health Corporation 458.28 Million USD 99.914%
Procaps Group S.A. 28.41 Million USD 98.613%
TherapeuticsMD, Inc. 6.53 Million USD 93.968%
Viatris Inc. 16.18 Billion USD 99.998%
Rockwell Medical, Inc. 8.29 Million USD 95.249%
Aytu BioPharma, Inc. 10.87 Million USD 96.378%
Tilray Brands, Inc. 287.93 Million USD 99.863%
PetIQ, Inc. 437.82 Million USD 99.91%
Talphera, Inc. - USD -Infinity%
Neurocrine Biosciences, Inc. 258.3 Million USD 99.847%
Alimera Sciences, Inc. 64.48 Million USD 99.389%
Assertio Holdings, Inc. 38.51 Million USD 98.977%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -191.66%
Avadel Pharmaceuticals plc 32.75 Million USD 98.797%
Hempacco Co., Inc. 5.93 Million USD 93.357%
Alvotech 1.02 Billion USD 99.962%
Lantheus Holdings, Inc. 616.12 Million USD 99.936%
Kamada Ltd. 7.43 Million USD 94.703%
Currenc Group, Inc. 2.5 Million USD 84.284%
Indivior PLC 235.66 Million USD 99.833%
Evoke Pharma, Inc. 5 Million USD 92.12%
Flora Growth Corp. 942 Thousand USD 58.174%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -1652.357%
Evolus, Inc. 120.35 Million USD 99.673%
HUTCHMED (China) Limited 48.18 Million USD 99.182%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 99.933%
Akanda Corp. 2.49 Million USD 84.222%